- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹570.6b
Operates as a pharmaceutical company in India.
500488
₹26,851.80
7D
6.1%
1Y
-22.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹406.7b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,400.60
7D
2.0%
1Y
-26.8%
Sanofi India
Market Cap: ₹79.4b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,446.85
7D
2.3%
1Y
-42.5%